19 Chronic kidney disease (CKD) - Part 2
Veterinary Clinical Podcasts
Dominic Barfield
5.0 • 643 Ratings
🗓️ 12 June 2014
⏱️ 43 minutes
🔗️ Recording | iTunes | RSS
🧾️ Download transcript
Summary
Chronic kidney disease (CKD) is a common problem in cats and dogs, especially as they get older. In the first podcast on CKD we discussed topics such as the anatomy and function of the kidney, why the kidney may become dysfunctional and what the consequences are, some terminology, and causes of kidney disease. In this second part we will look at clinical aspects of CKD in terms of patient approach and management, covering topics such as suspecting and making the diagnosis, IRIS staging, treatment and prognosis. I am joined once again by Dr Rosanne Jepson who is a Lecturer in Internal Medicine at the RVC and also a member of the Renal Replacement Therapy team at the QMHA. Rosanne has a special interest in nephrology in particular.
As mentioned in the podcast, do check out the International Renal Interest Society (IRIS) website.
As always, if you have any comments about this podcast, please get in touch (email sjasani@rvc.ac.uk; tweet @RoyalVetCollege using #saclinpod; or use the RVC's Facebook page).
Please rate the podcasts in iTunes and write a review too! Thanks.
Hosted on Acast. See acast.com/privacy for more information.
Transcript
Click on a timestamp to play from that location
| 0:00.0 | So hello, welcome back to this Small Animal Clinical podcast series, brought to you from the Royal |
| 0:05.4 | Rettany College in London. My name is Shailen Gisani. Today it's my great pleasure to welcome back to the podcast, Dr. |
| 0:11.9 | Roseanne Jepson. Rosanne, you'll remember, as a diplomat of the American College of Retton |
| 0:16.4 | Internal Medicine and a lecturer in internal medicine at the RVC's Queen Mother Hospital for Animals. |
| 0:22.4 | So thanks very much, Rosanne, for joining me again. And as of today, you are the most frequent |
| 0:27.3 | guest. I'm trying to think of the word there. A peer, I'm as much as a peer. On this podcast |
| 0:34.4 | series. So thank you very much for that as well. So Rosan, today is part two of our podcast on chronic kidney disease in dogs and cats. |
| 0:43.2 | In part one that I published a few weeks ago, we focused more on the kind of theoretical aspects. |
| 0:50.0 | And what I'd like to do today is to concentrate on the more clinical aspects of the approach |
| 0:55.2 | to and the management of the patient with chronic kidney disease. So I'd like to start by asking |
| 1:01.5 | you in what sorts of patients might you consider chronic kidney disease as a potential diagnosis? |
| 1:06.9 | So is there anything in the signament, history or indeed your physical exam that might kind of |
| 1:12.6 | increase your suspicion that that might be what you're dealing with with the patient in front of you? |
| 1:18.1 | Yeah. |
| 1:18.6 | So, I mean, I think the classic patient presenting with chronic kidney disease is going to be the older patient, |
| 1:27.0 | particularly if we're |
| 1:28.2 | thinking about tubular interstitial nephritis causing chronic kidney disease in both dogs and in cats. |
| 1:36.0 | So we're always going to be heightened to the possibility of KD in those older patients. |
| 1:41.2 | But certainly it can affect younger patients too, so I wouldn't rule it out. And then in terms |
| 1:46.9 | of the history, actually that's going to be some really important information for us. We're looking |
| 1:51.5 | for clinical signs potentially of polyurea and polydipsia. As the disease progresses, those |
| 1:59.0 | patients may have had some degree of weight loss. |
... |
Please login to see the full transcript.
Disclaimer: The podcast and artwork embedded on this page are from Dominic Barfield, and are the property of its owner and not affiliated with or endorsed by Tapesearch.
Generated transcripts are the property of Dominic Barfield and are distributed freely under the Fair Use doctrine. Transcripts generated by Tapesearch are not guaranteed to be accurate.
Copyright © Tapesearch 2026.

